唯久生物技术

Weijiu Biotech is a biotechnology company focused on the development of mRNA-based therapeutics and vaccines. The company utilizes a proprietary lipid nanoparticle (LNP) delivery platform to address unmet needs in infectious diseases and oncology. By integrating advanced computational biology with high-throughput screening, Weijiu Biotech optimizes mRNA sequences and delivery systems for enhanced stability and expression. Their pipeline includes several candidates targeting viral pathogens and solid tumors. The company is headquartered in Shanghai and maintains research and manufacturing facilities in Suzhou to support its end-to-end development strategy. Weijiu Biotech aims to establish a leading position in the global mRNA drug market through continuous innovation in delivery technology.